Melissa Davis

Lessons Learned From the Hedge Fund Crisis

twocents@thestreet.com (Melissa Davis) — Fri, 20 Feb 2009 19:55 GMT

Last year brought enough investor pain to reshape the entire industry.

Why There's Still Hope for Detroit

twocents@thestreet.com (Melissa Davis) — Tue, 27 Jan 2009 20:56 GMT

David Cole, chairman of the Center for Automotive Research, believes there could be a happy ending for GM and Ford.

GM's Biggest Foe Could Be Time

twocents@thestreet.com (Melissa Davis) — Fri, 16 Jan 2009 20:54 GMT

The automaker already has received union concessions, but shareholders face dilution over how GM reduces its debt load.

Humana's Learning to Change With the Times

twocents@thestreet.com (Melissa Davis) — Fri, 05 Dec 2008 20:00 GMT

Even if Democrats manage to end its "private fee-for-service" business, the company's confident that everything will work out in the end.

Health Insurers See 'Universal' Opportunity

twocents@thestreet.com (Melissa Davis) — Mon, 24 Nov 2008 18:02 GMT

Companies such as Humana and UnitedHealth could benefit if the Democrats institute universal health care.

Hospitals Face a Baby-Boom Bust

twocents@thestreet.com (Melissa Davis) — Wed, 12 Nov 2008 18:48 GMT

For-profit providers face a tough road amid likely Medicare reforms.

Pickens Fueling Natural Gas Push

twocents@thestreet.com (Melissa Davis) — Tue, 04 Nov 2008 18:53 GMT

The longtime oilman wants to cut our dependence on foreign oil.

Tenet Healthcare Shares Punished

twocents@thestreet.com (Melissa Davis) — Tue, 04 Nov 2008 17:43 GMT

The company gets a little murkier on 2009.

GE Set for a Pickens Windfall

twocents@thestreet.com (Melissa Davis) — Mon, 03 Nov 2008 19:05 GMT

The company stands to make out well if the oilman's alternative-energy plan moves forward.

CVS Slashes Generic Drug Prices

twocents@thestreet.com (Melissa Davis) — Fri, 31 Oct 2008 20:41 GMT

The drugstore chain is coming out with a health care pass that will lower generic drug prices.

Pickens Primes Pump for a Mighty Wind

twocents@thestreet.com (Melissa Davis) — Wed, 29 Oct 2008 17:13 GMT

The legendary oilman says it's time to break our addiction on fuel oil and explore alternative energy sources.

Zimmer Shares Slump on Forecast

twocents@thestreet.com (Melissa Davis) — Thu, 23 Oct 2008 17:58 GMT

The device maker reels in its full-year forecast.

Wellpoint Hit by Financial Meltdown

twocents@thestreet.com (Melissa Davis) — Wed, 22 Oct 2008 17:30 GMT

The health insurer's earnings were affected by bad investments in the financial industry.

Longs Shareholders Cinch CVS Caremark Deal

twocents@thestreet.com (Melissa Davis) — Mon, 20 Oct 2008 17:12 GMT

The deal was completed Mondayl when Longs shareholders agreed to accept it.

Stryker Just Shy of Estimates

twocents@thestreet.com (Melissa Davis) — Thu, 16 Oct 2008 21:50 GMT

The orthopedic device maker reported strong gains in revenue and profits for the quarter.

UnitedHealth's Profits Fall on Higher Costs

twocents@thestreet.com (Melissa Davis) — Thu, 16 Oct 2008 17:19 GMT

The health insurer struggled with rising medical costs and investment losses during the quarter.

Walgreen's CEO Retires

twocents@thestreet.com (Melissa Davis) — Fri, 10 Oct 2008 17:36 GMT

Jeffrey Rein retires two days after Walgreens made an unsuccessful attempt to take over Longs Drug Stores.

Longs' Options Limited After Walgreen's Exit

twocents@thestreet.com (Melissa Davis) — Thu, 09 Oct 2008 21:33 GMT

Longs Drug Stores finds itself looking again at CVC-Caremark's offer.

Arthrocare Gets No Medicare Love

twocents@thestreet.com (Melissa Davis) — Thu, 02 Oct 2008 16:13 GMT

A ruling by regulators may put sales of the company's spinal device in jeopardy.

Walgreen Wades into Antitrust Waters

twocents@thestreet.com (Melissa Davis) — Tue, 30 Sep 2008 20:56 GMT

The company sees Hawaii as a key market.

Walgreen Feels Margin Pain

twocents@thestreet.com (Melissa Davis) — Mon, 29 Sep 2008 18:06 GMT

The company boosts profit by 12%, but it comes at a price.

Longs Sticking to CVS Merger Plan

twocents@thestreet.com (Melissa Davis) — Wed, 17 Sep 2008 20:21 GMT

But shareholders keep wanting a more serious look at Walgreen's higher bid.

HMA's CEO Takes a Hike

twocents@thestreet.com (Melissa Davis) — Mon, 15 Sep 2008 18:23 GMT

After a year on the job, Burke Whitman sees military service as the better option.

CVS Angles for Longs' Real Estate Bounty

twocents@thestreet.com (Melissa Davis) — Mon, 15 Sep 2008 17:20 GMT

Shareholders say the buyout target has undervalued its real estate portfolio -- the real prize of any merger.

Longs Drugs CEO Set for Fat Merger Payday

twocents@thestreet.com (Melissa Davis) — Mon, 15 Sep 2008 16:52 GMT

Warren Bryant could snag up to $23 million, if CVS' buyout goes through. But some shareholders want a better deal.

Arthrocare Device Use Draws More Scrutiny

twocents@thestreet.com (Melissa Davis) — Thu, 28 Aug 2008 18:22 GMT

A mounting FBI probe is looking into surgeries requiring one of the company's products.

Amedisys' CFO Carousel Misses the Mark

twocents@thestreet.com (Melissa Davis) — Wed, 27 Aug 2008 18:02 GMT

The company can't seem to keep a financial chief. Maybe the problem is higher up?

Schering Regroups After FDA Rejection

twocents@thestreet.com (Melissa Davis) — Wed, 13 Aug 2008 21:38 GMT

The company plans to rely on the sales of other drugs, particularly in overseas markets.

CVS Caremark Eyes Westward Expansion

twocents@thestreet.com (Melissa Davis) — Wed, 13 Aug 2008 20:06 GMT

Its deal to acquire Longs gives it potentially lucrative properties in California and Hawaii.

Schering Drug Derailed by Power of One

twocents@thestreet.com (Melissa Davis) — Wed, 13 Aug 2008 14:10 GMT

A single patient's allergic reaction may have delayed U.S. approval by up to three years.